Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 23/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/10

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 11: Figure S11

Description: Differentially abundant taxa between the Naive group and HRZ (H-Isoniazid, R-Rifampin, Z-Pyrazinamide) treatment group.

Abundance in Group 1: decreased abundance in HRZ(H-Isoniazid, R-Rifampin, Z-Pyrazinamide)

NCBI	Quality Control	Links
Acetanaerobacterium
Acetivibrio
Arthrobacter
Bacteroides
Blautia
Clostridium
Coprobacter
Dorea
Erysipelotrichaceae
Guggenheimella
Hydrogenoanaerobacterium
Intestinimonas
Lactobacillus
Oxobacter
Pelotomaculum
Pseudobacteroides
Pseudobutyrivibrio
Robinsoniella
Romboutsia
Roseburia
Ruminococcus
Shewanella
Sporobacter
Stomatobaculum
Turicibacter
Tyzzerella

Revision editor(s): KateRasheed